Comparative efficacy of seven Chinese patent medicines for early diabetic kidney disease: A Bayesian network meta-analysis
Background: Bailing Capsule (BLC), Jinshuibao (JSB), Huangkui Capsule (HKC), Uremic Clearance Granule (UCG), Tripterygium glycosides (TG), Compound Xueshuantong Capsule (CXC), and Shenyan Kangfu Tablet (SYKFT) as classic Chinese patent medicines (CPMs), have been widely used and shown beneficial eff...
Saved in:
Main Authors: | Jie Zhao (Author), Jun Ai (Author), Chao Mo (Author), Wei Shi (Author), LiFeng Meng (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative efficacy, safety and cost of oral Chinese patent medicines for rheumatoid arthritis: a Bayesian network meta-analysis
by: Dan Zhang, et al.
Published: (2020) -
Comparative efficacy of Chinese patent medicines in patients with carotid atherosclerotic plaque: a Bayesian network meta− analysis
by: Wenquan Su, et al.
Published: (2023) -
Comparative efficacy and safety of various Chinese patent medicines combined with western medicine for adults with insomnia: A Bayesian network meta-analysis of randomized controlled trials
by: Ciyan Peng, et al.
Published: (2023) -
The efficacy of azithromycin combined with seven types of Chinese medicine injections in the treatment of Mycoplasma pneumoniae pneumonia in children: a systematic review and Bayesian network meta-analysis
by: Xinggui Huang, et al.
Published: (2024) -
Clinical efficacy, safety, and cost of nine Chinese patent medicines combined with ACEI/ARB in the treatment of early diabetic kidney disease: A network meta-analysis
by: Jiarong Liu, et al.
Published: (2022)